2017


March 2nd,The 3rd Annual Dermatology Innovation Forum, Orlando


March 3rd-7th, American Academy of Dermatology, Orlando


March 19th-22nd, BIO Europe Spring 2017, Barcelona


May 8th-10th, Bio Trinity, London


May 22nd-23rd, Bio Equity, Paris


May 25th-28th, European Academy of Dermatology and Venereology, Brussels


June 19th-22nd, BIO, San Diego

2016

UPCOMING EVENTS

 Edesa Licenses Rights to ASF-1096 for Anorectal Disorders from Cipher Pharmaceuticals Inc.

June 20, 2016  Edesa Biotech Inc. ("Edesa") has licensed the rights to ASF-1096 for use in anorectal disorders from Cipher Pharmaceuticals Inc. ASF-1096 is a phase II product candidate that Cipher is investigating as a treatment for selected inflammatory skin disorders. Cipher acquired the global rights to the product in February 2015. Under this agreement, Cipher retains all rights to ASF-1096 for dermatological conditions.

2016


June 6-9: BIO International Conference, San Francisco


May 22-14: Digestive Disease Week, San Diego


March 4-8, American Academy of Dermatology, Washington D.C.


January 11-15: JP Morgan Annual Healthcare Conference, San Francisco





2015


November 2-4: BIO-Europe, Munich, Germany


October 20-21:  14th Annual BIO Investor Forum, San Francisco

NEWS

PAST EVENTS